Literature DB >> 34233868

Rare case of obstetric cholestasis presenting in the first trimester following in vitro fertilisation.

Krystal Koh1, Rajeswari Kathirvel2,3, Manisha Mathur2,3.   

Abstract

Intrahepatic cholestasis of pregnancy (ICP) generally presents in the third trimester with pruritus without a rash, characterised by elevated bile acids, with or without transaminitis and hyperbilirubinaemia. Risk factors include a family history of cholestasis, South Asian ethnicity, multifetal gestation, in vitro fertilisation (IVF) and history of hepatitis or biliary disorders.IVF involves the use of high dose gonadotropin stimulation and human chorionic gonadotropin trigger. High doses of progesterone supplementation are additionally given after embryo transfer. The increase in oestrogen and progesterone levels early on in the pregnancy is a possible explanation for the development of ICP in IVF pregnancies at earlier gestations.We present a rare case of iatrogenic ICP presenting in the first trimester in a pregnancy conceived by IVF. Unlike other cases reported, our patient did not have recurrence of ICP in the third trimester, and also had no history of ICP in her first pregnancy. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  liver disease; obstetrics and gynaecology; reproductive medicine

Mesh:

Year:  2021        PMID: 34233868      PMCID: PMC8264887          DOI: 10.1136/bcr-2021-244254

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  2 in total

Review 1.  Pruritus in Pregnancy.

Authors:  Aleksandra A Stefaniak; Manuel P Pereira; Claudia Zeidler; Sonja Ständer
Journal:  Am J Clin Dermatol       Date:  2022-02-21       Impact factor: 7.403

2.  Norethisterone-induced cholestasis: A case report.

Authors:  Safa Moussaoui; Mehdi Abdelwahed; Nabil Ben Chaaben; Ahlem Bellalah; Najah Ben Fadhel; Arwa Guediche; Mejda Zakhama; Ramzi Tababi; Karim Aouam; Zakhama Abdelfattah; Hichem Loghmari; Leila Safer
Journal:  Clin Case Rep       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.